Skip to content

The comparison of the effect of calcium channel blockers on blood pressure lowering and presevation of renal function in refractory hypertensive patients

The comparison of the effect of calcium channel blockers on blood pressure lowering and presevation of renal function in refractory hypertensive patients - The comparison of the effect of CCBs on BP and renal function in refractory hypertensive patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000004909
Enrollment
30
Registered
2011-02-01
Start date
2011-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory hypertension

Interventions

Nifedipine CR 40mg (6 months), then Amlodipine 5mg (6 months) Amlodipine 5mg (6 months), then Nifedipine CR 40mg (6 months)

Sponsors

St. Marianna University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: refractory hypertensive patients with 1. office blood pressure>=140/90 mmHg or more 2. DM, CKD, MI patients: BP>=130/80 mmHg or more (*patients with proteinuria BP>=1g/gCr: 125/75 mmHg) 3. CVA patients: BP>=140/90 mmHg or more

Exclusion criteria

Exclusion criteria: 1. taking Nifedipine or Amlodipine 2. history of hypersensitivity to Amlodipine and/or Nifedipine 3. secondary hypertension 4. pregnant, becoming pregnant 5. cardiogenic shock 6. planning dialysis within 1 year 7. regarded as inadequate for enrollment by investigator

Design outcomes

Primary

MeasureTime frame
Blood pressure lowering between 2 remedies (delta SBP and delta DBP after 3, 6, and 12 month)

Secondary

MeasureTime frame
1)achievement rate of target blood pressure 2)change in renal dysfunction 3)change in hs-CRP 4)change in endocrine system

Countries

Japan

Contacts

Public ContactTakashi Yasuda

St. Marianna University School of Medicine Nephrology and Hypertension

044-977-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026